{"id":724,"date":"2026-09-01T15:21:54","date_gmt":"2026-09-01T15:21:54","guid":{"rendered":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/"},"modified":"2026-09-01T15:32:23","modified_gmt":"2026-09-01T15:32:23","slug":"cjc-1295-dac-randomized-human-pharmacology","status":"publish","type":"case_study","link":"https:\/\/nhdbio.com\/cn\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","title":{"rendered":"CJC-1295 \u548c DAC\uff1a\u968f\u673a\u4eba\u4f53\u836f\u7406\u5b66\u548c\u767d\u86cb\u767d\u7ed3\u5408\u8fb9\u754c"},"content":{"rendered":"<h2>\u8eab\u4efd\u95ee\u9898\u5148\u4e8e\u7ed3\u679c<\/h2>\n<p>\u6240\u5f15\u7528\u7684\u5316\u5408\u7269\u88ab\u8bbe\u8ba1\u4e3a\u7ed3\u5408\u5185\u6e90\u6027\u767d\u86cb\u767d\u7684\u957f\u6548 GHRH \u7c7b\u4f3c\u7269\u3002\u8be5\u8bbe\u8ba1\u7279\u5f81\u662f\u836f\u4ee3\u52a8\u529b\u5b66\u95ee\u9898\u7684\u6838\u5fc3\u3002\u641c\u7d22\u9875\u9762\u7ecf\u5e38\u5c06\u201cwith DAC\u201d\u548c\u201cwithout DAC\u201d\u6298\u53e0\u6210\u4e00\u4e2a\u540d\u79f0\uff0c\u4f46\u8fd9\u6837\u505a\u4f1a\u6539\u53d8\u5206\u5b50\u8eab\u4efd\u5e76\u4f7f\u62a5\u544a\u7684\u534a\u8870\u671f\u7684\u76f4\u63a5\u8f6c\u79fb\u65e0\u6548\u3002<\/p>\n<h2>\u8bd5\u9a8c\u6d4b\u91cf\u4e86\u4ec0\u4e48<\/h2>\n<p>\u8fd9\u4e24\u9879\u8bd5\u9a8c\u662f\u968f\u673a\u3001\u5b89\u6170\u5242\u5bf9\u7167\u3001\u53cc\u76f2\u3001\u5242\u91cf\u9012\u589e\u7684\u3002\u4ed6\u4eec\u7684\u4e3b\u8981\u7ed3\u679c\u662f\u5faa\u73af GH \u548c IGF-I \u66b4\u9732\u4ee5\u53ca\u836f\u4ee3\u52a8\u529b\u5b66\u53c2\u6570\u3002\u8fd9\u4e9b\u662f\u836f\u7406\u5b66\u7ec8\u70b9\u3002\u5b83\u4eec\u4e0d\u662f\u6539\u5584\u5065\u5eb7\u3001\u8eab\u4f53\u6210\u5206\u6216\u8868\u73b0\u7684\u76f4\u63a5\u8861\u91cf\u6807\u51c6\u3002<\/p>\n<h2>\u62a5\u544a\u7684\u65f6\u95f4\u8fdb\u7a0b<\/h2>\n<p>\u4f5c\u8005\u62a5\u544a\u4e86\u6301\u7eed\u7684\u3001\u5242\u91cf\u4f9d\u8d56\u6027\u7684 GH \u548c IGF-I \u589e\u52a0\u4ee5\u53ca\u4ee5\u5929\u4e3a\u5355\u4f4d\u7684\u4f30\u8ba1\u534a\u8870\u671f\u3002\u4e00\u9879\u914d\u5957\u7814\u7a76\u62a5\u544a\u79f0\uff0c\u5728\u957f\u65f6\u95f4\u523a\u6fc0\u4e0b\uff0c\u4ecd\u53ef\u89c2\u5bdf\u5230\u8109\u52a8\u7684 GH \u5206\u6ccc\u3002\u8fd9\u4e9b\u8bb0\u5f55\u4ec5\u652f\u6301 DAC \u8868\u683c\u7684\u673a\u68b0\u548c\u65f6\u95f4\u8fc7\u7a0b\u8ba8\u8bba\u3002<\/p>\n<div class=\"pfm-case-callout\"><strong>\u59d3\u540d\u68c0\u67e5\uff1a<\/strong> \u4f7f\u7528\u7ecf\u5178\u7684 CJC-1295 \u8bd5\u9a8c\u6765\u63cf\u8ff0\u201c\u6ca1\u6709 DAC \u7684 CJC-1295\u201d\u7684\u9875\u9762\u6b63\u5728\u6df7\u5408\u4e24\u79cd\u4e0d\u540c\u7684\u6750\u6599\u3002\u5728\u91cd\u590d\u4f7f\u7528\u4efb\u4f55\u7f16\u53f7\u4e4b\u524d\uff0c\u4ea7\u54c1\u6807\u8bc6\u5fc5\u987b\u4e0e\u5f15\u7528\u7684\u5e72\u9884\u63aa\u65bd\u76f8\u5339\u914d\u3002<\/div>\n<h2>\u7814\u7a76\u6ca1\u6709\u786e\u5b9a\u4ec0\u4e48<\/h2>\n<p>\u77ed\u671f\u7684\u65e9\u671f\u6fc0\u7d20\u548c\u66b4\u9732\u6570\u636e\u5e76\u4e0d\u80fd\u786e\u5b9a\u6cbb\u7597\u6548\u679c\u3001\u957f\u671f\u5b89\u5168\u6027\u6216\u5546\u4e1a\u6279\u6b21\u7684\u8d28\u91cf\u3002\u5f53\u524d\u6279\u6b21\u9700\u8981\u6709\u81ea\u5df1\u7684\u8eab\u4efd\u3001\u5316\u9a8c\u548c\u653e\u884c\u6587\u4ef6\uff1b\u6587\u732e\u65e0\u6cd5\u66ff\u4ee3\u8fd9\u4e9b\u63a7\u5236\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>\u4ed4\u7ec6\u9605\u8bfb\u5728\u5065\u5eb7\u6210\u4eba\u4e2d\u8fdb\u884c\u7684\u4e24\u9879\u968f\u673a\u5242\u91cf\u9012\u589e\u7814\u7a76\uff0c\u91cd\u70b9\u5173\u6ce8 GH \u548c IGF-I \u65f6\u95f4\u8fdb\u7a0b\u3001\u4f30\u8ba1\u534a\u8870\u671f\u4ee5\u53ca\u4e3a\u4ec0\u4e48\u7814\u7a76\u7ed3\u679c\u4e0d\u9002\u7528\u4e8e\u6ca1\u6709 DAC \u7684 CJC-1295\u3002<\/p>","protected":false},"author":0,"featured_media":852,"template":"","class_list":["post-724","case_study","type-case_study","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CJC-1295 DAC Human Trial: GH, IGF-I and Half-Life<\/title>\n<meta name=\"description\" content=\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/cn\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary\" \/>\n<meta property=\"og:description\" content=\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/cn\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T15:32:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\",\"name\":\"CJC-1295 DAC Human Trial: GH, IGF-I and Half-Life\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"datePublished\":\"2026-09-01T15:21:54+00:00\",\"dateModified\":\"2026-09-01T15:32:23+00:00\",\"description\":\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"width\":1672,\"height\":941,\"caption\":\"Editorial laboratory illustration; not an image of a supplied lot or a reported analytical result.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u6848\u4f8b\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CJC-1295 DAC \u4eba\u4f53\u8bd5\u9a8c\uff1aGH\u3001IGF-I \u548c\u534a\u8870\u671f","description":"\u4ed4\u7ec6\u9605\u8bfb\u5728\u5065\u5eb7\u6210\u4eba\u4e2d\u8fdb\u884c\u7684\u4e24\u9879\u968f\u673a\u5242\u91cf\u9012\u589e\u7814\u7a76\uff0c\u91cd\u70b9\u5173\u6ce8 GH \u548c IGF-I \u65f6\u95f4\u8fdb\u7a0b\u3001\u4f30\u8ba1\u534a\u8870\u671f\u4ee5\u53ca\u4e3a\u4ec0\u4e48\u7814\u7a76\u7ed3\u679c\u4e0d\u9002\u7528\u4e8e\u6ca1\u6709 DAC \u7684 CJC-1295\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/cn\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","og_locale":"zh_CN","og_type":"article","og_title":"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary","og_description":"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.","og_url":"https:\/\/nhdbio.com\/cn\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","og_site_name":"NHD","article_modified_time":"2026-09-01T15:32:23+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","url":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","name":"CJC-1295 DAC \u4eba\u4f53\u8bd5\u9a8c\uff1aGH\u3001IGF-I \u548c\u534a\u8870\u671f","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","datePublished":"2026-09-01T15:21:54+00:00","dateModified":"2026-09-01T15:32:23+00:00","description":"\u4ed4\u7ec6\u9605\u8bfb\u5728\u5065\u5eb7\u6210\u4eba\u4e2d\u8fdb\u884c\u7684\u4e24\u9879\u968f\u673a\u5242\u91cf\u9012\u589e\u7814\u7a76\uff0c\u91cd\u70b9\u5173\u6ce8 GH \u548c IGF-I \u65f6\u95f4\u8fdb\u7a0b\u3001\u4f30\u8ba1\u534a\u8870\u671f\u4ee5\u53ca\u4e3a\u4ec0\u4e48\u7814\u7a76\u7ed3\u679c\u4e0d\u9002\u7528\u4e8e\u6ca1\u6709 DAC \u7684 CJC-1295\u3002","breadcrumb":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","width":1672,"height":941,"caption":"Editorial laboratory illustration; not an image of a supplied lot or a reported analytical result."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"\u6848\u4f8b","item":"https:\/\/nhdbio.com\/case-studies\/"},{"@type":"ListItem","position":3,"name":"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u591a\u80bd\u539f\u6599\u4e0e\u591a\u80bd\u5b9a\u5236\u5408\u6210","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/case_study\/724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/types\/case_study"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/case_study\/724\/revisions"}],"predecessor-version":[{"id":729,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/case_study\/724\/revisions\/729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/media\/852"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/media?parent=724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}